Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookBaseline Assessment of the Nigerian Pharmaceutical Sector (WHO; 2002; 62 pages)
View the documentAcknowledgements
View the documentList of abbreviations
View the documentExecutive summary
Open this folder and view contentsIntroduction
View the documentTHE HEALTH STATUS OF NIGERIANS
View the documentUnder-Five Morbidity and Mortality Rates
Open this folder and view contentsBASIC HEALTH INDICATORS
View the documentStructure of the health system in Nigeria
Open this folder and view contentsDRUG SECTOR ORGANISATION
Open this folder and view contentsINTRODUCTION TO THE STUDY
Open this folder and view contentsSTUDY DESIGN AND METHODOLOGY
Open this folder and view contentsRESULTS AND ANALYSIS ACCESS
close this folderQUALITY AND SAFETY
View the documentRational use of drugs indicators
View the documentPrescribing of Drugs
View the documentPatient Care
Open this folder and view contentsINTERPRETATION OF RESULTS
Open this folder and view contentsCONCLUSIONS AND RECOMMENDED INTERVENTIONS
Open this folder and view contentsANNEX 1
Open this folder and view contentsANNEX 2
 

Patient Care

It was not possible to gather data on patient care indicators as clinic attendance was very low in 23 out of 34 health facilities. Some primary health care facilities had a maximum attendance rate of only three patients per day. Some other facilities were closed and health workers had to be brought from their homes or market places to allow data collectors interview them. However, attendance rate at the secondary health facilities was quite high and enough patients were interviewed. An exception was the South West zone where the state government offered free medical treatment to the populace and so attendance at the PHC level was high.

to previous sectionto next section

Please provide your feedback English  |  French